Material in Medical Technology
Navigation Links
Material in Medical Technology
... uncertainties and other factors could lead to material differences between the actual future results, ... with third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with ...
... uncertainties and other factors could lead to material differences between the actual future results, ... third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with ...
... in biodefense. The technology supports the practice of inserting genetic material from the disease-causing virus or parasite into a "vehicle" called a vector, which then delivers the immunogenic material directly to the immune system. Most vectors are based on an adenovirus, ...
... "This data demonstrates the unique potential of the extracellular matrix material in cardiac applications," said Beecher Lewis, President and COO of ... were discovered at Purdue University. The decellularized matrix material serves as a scaffold to allow adjacent tissues to deliver cells and ...
... since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including ...
... A/Indonesia/05/2005 avian influenza virus. The VLPs lack viral genetic material and therefore cannot replicate or cause disease. Commenting on the ... vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection ...
... and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products ...
... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
... on current assumptions and forecasts made by Daiichi Sankyo group. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
... desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry-based nucleic acid analysis platform that quantitatively measures genetic target material and its variations in a rapid, accurate, and cost efficient manner. SEQUENOM's MassARRAY system facilitates a number of nucleic acid analysis ...
... disease outcome in these patients. Dr. Talor will also discuss the objectives of the collaborative study between the NIH, NCI under a current material Transfer Agreement. This work is aimed at elucidating the tumor microenvironment changes, at the molecular level, brought about by Multikine ...
... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
... of other regulatory agencies worldwide that relate to those projects; dependence on the availability and cost of raw materials; dependence on no material interruptions in supply by contract manufacturers of King's products; dependence on King's compliance with FDA and other government regulations that ...
... with an audience of their peers through interactive complex case presentations. This forum will encourage open and critical discussion of the material presented, as well as relevant "standards of care." The overriding goal of this meeting is to emphasize the role of critical thinking and clinical ...
... on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
... and MAA filings. Further analyses of the CAPACITY results will be conducted in the future and additional observations may be made which may lead to material change in the company's current regulatory strategy for pirfenidone, including a decision by the company not to proceed with either or both of its ...
... changes made in transferring the manufacturing process for Acetavance may result in a lack of comparability between the commercial product and the material used in clinical trials, and that the FDA may require the company to perform additional non-clinical or clinical studies; the potential that the FDA ...
... on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
... drug eluting coronary stent. Abbott's bioabsorbable everolimus eluting coronary device is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as absorbable sutures. As with a metallic stent, Abbott's bioabsorbable device is designed to restore ...
... technologies compare and contrast a specimen's DNA to the DNA of a healthy individual to identify, at a high resolution, extra or missing genetic material in the specimen. These technologies can detect a proportion of additional abnormalities even in patients who have already had extensive cytogenetic ...
Cancer Research 'David' Hopes to Slay 'Cancer Goliath'
... treatment. They have now confirmed an anti-cancer material which they gave the laboratory name, ... specific anti-cancer antibodies. The active material is a biological agent resulting from a ... CEO of CHAI Foundation. The anti-cancer material was clinically tested outside the U.S. by Dr. ...... uncertainties and other factors could lead to material differences between the actual future results, ... third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with ...
Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
... LOS ANGELES, Feb. 5 /PRNewswire/ -- New polymer material designed to stop bone bleeding in surgery reduces ... expensive and most commonly used bone hemostasis material despite its well-documented side effects: ... infection and the separation of the sternum. The material is used in cardiac, orthopedic, oral, and ...DuPont Provides Technology for Washington Hospital Center's Emergency Department
... because it is a seamless, easy-to-clean surface material ideally suited for healthcare environments," said ... 193 sheets and 17 sinks made of the solid surface material to this phase of the ER One project. ... high-performing, easy-to-maintain solid surface material that, when properly used or cleaned, does ...Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
... study suggest that the elasticity (low stiffness) of Trabecular Metal material may induce a transfer of stresses to the periacetabular bone that more ... seen around traditional acetabular implants." Trabecular Metal material is a structural biomaterial whose cellular architecture resembles bone and ...Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
... provide surgeons with greater flexibility to cut, shape and suture the material to fit each patient's needs. Based on available data, Osteotech estimates ... HCT platform, DuraTech is an engineered nano-structure human collagen material that provides a porous scaffold to facilitate cellular in-growth and ...Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
... surgeons with the clinical flexibility to cut, shape and suture the material to fit each patient's needs. Based on available data, Osteotech estimates ... technology, DuraTech is an engineered nano-structure human collagen material that provides a porous scaffold for rapid cellular in-growth to facilitate ...Ceremed's OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
... wax, a beeswax-based product, is the most commonly used bone hemostasis material despite its well-documented side effects. Numerous studies have indicated ... We are able to custom-manufacture compounds using each OEM proprietary material in combination with the AOC carrier." About The Company: Ceremed, Inc. ...... in biodefense. The technology supports the practice of inserting genetic material from the disease-causing virus or parasite into a "vehicle" called a vector, which then delivers the immunogenic material directly to the immune system. Most vectors are based on an adenovirus, ...
... "This data demonstrates the unique potential of the extracellular matrix material in cardiac applications," said Beecher Lewis, President and COO of ... were discovered at Purdue University. The decellularized matrix material serves as a scaffold to allow adjacent tissues to deliver cells and ...
... since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including ...
... A/Indonesia/05/2005 avian influenza virus. The VLPs lack viral genetic material and therefore cannot replicate or cause disease. Commenting on the ... vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection ...
EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
... since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including ...EpiCept Reports Regulatory Progress on Ceplene(TM)
... since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including ...... and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products ...
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
... since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including ...... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
Cyberonics Provides Update on Depression Post-Approval Study
... management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating ...AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
... it has completed process development and preclinical immunogenicity studies of its H1N1 (swine) influenza vaccine and will manufacture clinical trial material by the end of the month. This vaccine has shown good production yields as well as excellent immunogenicity, even after just a single inoculation. ...... on current assumptions and forecasts made by Daiichi Sankyo group. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
... desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry-based nucleic acid analysis platform that quantitatively measures genetic target material and its variations in a rapid, accurate, and cost efficient manner. SEQUENOM's MassARRAY system facilitates a number of nucleic acid analysis ...
... disease outcome in these patients. Dr. Talor will also discuss the objectives of the collaborative study between the NIH, NCI under a current material Transfer Agreement. This work is aimed at elucidating the tumor microenvironment changes, at the molecular level, brought about by Multikine ...
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
... Animal tissue implants are subject to calcium deposition and hardening, due to the body's ability to recognize them as foreign. Synthetic material lacks the performance characteristics of tissue and causes an inflammatory response. ECM, however, leads to growth of functional tissue where ...... Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. The scientific information discussed in this ...
... of other regulatory agencies worldwide that relate to those projects; dependence on the availability and cost of raw materials; dependence on no material interruptions in supply by contract manufacturers of King's products; dependence on King's compliance with FDA and other government regulations that ...
New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
... rate to 24 months versus a 50% survival rate for the control group rats that were not fed prebiotics. Additionally, the "prebiotic" rats showed material reductions in cholesterol and body weight versus the control group. Significantly, the prebiotic used in the study was oligofructose ...When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research
... health, mental health and hormonal balance. About Natural Health International Natural Health International was founded in 1997 as a raw material supply business in Sydney, Australia, that today has expanded internationally and merged with a leading research and development company. One of the ...... with an audience of their peers through interactive complex case presentations. This forum will encourage open and critical discussion of the material presented, as well as relevant "standards of care." The overriding goal of this meeting is to emphasize the role of critical thinking and clinical ...
Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
... assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...... on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
... and MAA filings. Further analyses of the CAPACITY results will be conducted in the future and additional observations may be made which may lead to material change in the company's current regulatory strategy for pirfenidone, including a decision by the company not to proceed with either or both of its ...
... changes made in transferring the manufacturing process for Acetavance may result in a lack of comparability between the commercial product and the material used in clinical trials, and that the FDA may require the company to perform additional non-clinical or clinical studies; the potential that the FDA ...
... on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These ...
Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers
... to chop up large molecules into smaller control molecules that help regulate the output of many of the 30,000 human genes. The short bits of genetic material it produces during its dicing activities are termed microRNAs. "Prior research showed that the microRNA profiles of cancer cells are different ...Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
... immune system supporter. Itochu partners with Optigenex under an Exclusive Supply and Trademark Licensing Agreement to market AC-11(R) bulk material and consumer products containing AC-11(R) under sublicenses in Japan and several other Asian countries. Daniel Zwiren, president and CEO of ...... drug eluting coronary stent. Abbott's bioabsorbable everolimus eluting coronary device is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as absorbable sutures. As with a metallic stent, Abbott's bioabsorbable device is designed to restore ...
... technologies compare and contrast a specimen's DNA to the DNA of a healthy individual to identify, at a high resolution, extra or missing genetic material in the specimen. These technologies can detect a proportion of additional abnormalities even in patients who have already had extensive cytogenetic ...
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
... eluting coronary stent out to two years. Abbott's bioabsorbable everolimus eluting coronary device is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as dissolvable sutures. As with a metallic stent, Abbott's bioabsorbable stent is designed to restore ...Other ContentsseptumserologyserologyironironironironironironironironcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumphosphorusphosphorusphosphorusphosphorusphosphorusphosphoruseducationeducationeducationeducationeducationeducationeducationeducationassaultassaultassaultintercourseintercourseintercourseintercourseOther TagsClampsClampsMultidropCableAngleAngleRotorSmartSmartSmartSmartSmartLambdaLambdaOther Tagsconsulting 2consulting 3consulting 4definition 2
(Date:12/3/2009)... The UK leads the world when it comes to ... Physical Sciences Research Council (EPSRC) Chief Executive Dave Delpy ... has already brought us fuel cells, marine, wind and ... develop the capabilities of different solutions if we are ...
(Date:12/2/2009)... Latino men have a more difficult time quitting smoking ... but acculturation has no affect on Latinas odds of ... Cancer Epidemiology, Biomarkers & Prevention , a journal ... issue has a special focus on tobacco. , "Acculturation ...
(Date:12/2/2009)... cigarette smoking scenes in movies are more likely ... may be part of the acculturation process associated ... , "Our study supports an R-rating for smoking ... implementation of the World Health Organization Framework Convention ...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 1Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 3Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 1Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 2Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 3New Home Drug Hair Test Kit Now Available from Bartell Drugs 3B 0AHairConfirm Detects 90 Day Drug Use 26amp 3B Usage Frequency 48556 1New Home Drug Hair Test Kit Now Available from Bartell Drugs 3B 0AHairConfirm Detects 90 Day Drug Use 26amp 3B Usage Frequency 48556 2(Date:12/7/2009)... 7 Interleukin Genetics, Inc. (NYSE Amex: ... the State of New York,s Department of Health for ... Genetic Test that determines predisposition to severe periodontal disease ... all other States in the U.S. However, through ... the accuracy and reliability of results of laboratory tests, ...
(Date:12/7/2009)... Health Service (NHS), which manages 500 hospitals and over ... of an engaged staff: healthier and happier patients. As ... of care, many NHS hospitals are teaming up with ... train hospital leaders. ,, "Staff engagement is essential to ... Weeks, policy manager for NHS Employers, an organisation that ...
(Date:12/7/2009)... selected a Texas Wind Integration project team including Drummond Group ... smart grid demonstration project. Drummond Group,s role is overseeing the ... with strong support from the project stakeholders. , ... ... -- The Department of Energy has selected a ...
(Date:12/7/2009)... tax return by using the free tax calculator. Answer simple questions about ... ... can estimate their 2009 tax return by using the free tax calculator. , ... understand it. No more waiting or worrying about how much the return will ... everyone can use., , , Find out right now with a few ...
(Date:12/7/2009)... the University of Chicago have discovered a technique that ... sleep apnea (OSA) or habitual snoring by screening their ... of developing a relatively simple urine test that could ... need for costly and inconvenient sleep studies in children ... whom actually have OSA," said lead author David Gozal, ...
Breaking Medicine News(10 mins):Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 2Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 3Health News:The NHS to Improve Patient Care by Better Engaging Staff 2Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 2Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 3Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 4Health News:2009 Free Tax Return Calculator 2Health News:Urine test for pediatric obstructive sleep apnea possible 2[0] Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York[0] The NHS to Improve Patient Care by Better Engaging Staff[0] Drummond Group Awarded DOE Funds for Texas Wind Integration Project [1] 2009 Free Tax Return Calculator [0] Urine test for pediatric obstructive sleep apnea possible
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |